Cefaly® is an external trigeminal neurostimulation device for the prevention and treatment of migraine. It is applied to the forehead using a self-adhesive electrode positioned bilaterally over the upper branches of the trigeminal nerve which is involved in the migraine mechanism. The Cefaly® generates very precise electrical impulses allowing to stimulate the trigeminal nerve. Evidence-based for a preventive therapeutic effect as well as for an abortive effect.
The efficacy/safety profile is excellent exceeding that of most anti-migraine medication. It fulfills the unmet needs of the migraine medication and therefore it can be offered to patients in whom anti-migraine drugs are not tolerated or contraindicated, and it can be combined with those medications.